These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27582667)

  • 1. A Nose for Seizures: A Potential Role for Olfaction in the Co-Morbidity of Depression and Epilepsy?
    Christian CA
    Epilepsy Curr; 2016; 16(4):256-7. PubMed ID: 27582667
    [No Abstract]   [Full Text] [Related]  

  • 2. Seizure susceptibility and epileptogenesis in a rat model of epilepsy and depression co-morbidity.
    Epps SA; Tabb KD; Lin SJ; Kahn AB; Javors MA; Boss-Williams KA; Weiss JM; Weinshenker D
    Neuropsychopharmacology; 2012 Dec; 37(13):2756-63. PubMed ID: 22871911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric Co-morbidities in Women with Epilepsy.
    Sundar U; Honrao ST; Shah N
    J Assoc Physicians India; 2017 Dec; 65(12):30-32. PubMed ID: 29327519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postictal nose-rubbing in the diagnosis, lateralization, and localization of seizures.
    Geyer JD; Payne TA; Faught E; Drury I
    Neurology; 1999 Mar; 52(4):743-5. PubMed ID: 10078720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the nose: Olfactory disturbances in patients with transient epileptic amnesia.
    Savage SA; Butler CR; Milton F; Han Y; Zeman AZ
    Epilepsy Behav; 2017 Jan; 66():113-119. PubMed ID: 28038387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of olfaction in patients with empty nose syndrome after submucosal implantation.
    Chang FY; Fu CH; Lee TJ
    Am J Otolaryngol; 2021; 42(4):102989. PubMed ID: 33676069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy.
    Mazarati AM; Shin D; Kwon YS; Bragin A; Pineda E; Tio D; Taylor AN; Sankar R
    Neurobiol Dis; 2009 Jun; 34(3):457-61. PubMed ID: 19285131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postictal nose wiping: a lateralizing sign in temporal lobe complex partial seizures.
    Leutmezer F; Serles W; Lehrner J; Pataraia E; Zeiler K; Baumgartner C
    Neurology; 1998 Oct; 51(4):1175-7. PubMed ID: 9781551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of self-efficacy, alexithymia and multiple traumas on posttraumatic stress disorder and psychiatric co-morbidity following epileptic seizures: a moderated mediation analysis.
    Chung MC; Allen RD; Dennis I
    Psychiatry Res; 2013 Dec; 210(3):1033-41. PubMed ID: 23978734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The co-morbidity of depression and epilepsy: epidemiology, etiology, and treatment.
    Harden CL
    Neurology; 2002 Sep; 59(6 Suppl 4):S48-55. PubMed ID: 12270969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In adolescents with epilepsy, high scores of anxiety and depression are associated with occurrence of seizures in public places.
    Siqueira NF; Oliveira FL; Siqueira JA; Souza EA
    Arq Neuropsiquiatr; 2015 Mar; 73(3):205-11. PubMed ID: 25807125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic background contributes to the co-morbidity of anxiety and depression with audiogenic seizure propensity and responses to fluoxetine treatment.
    Sarkisova KY; Fedotova IB; Surina NM; Nikolaev GM; Perepelkina OV; Kostina ZA; Poletaeva II
    Epilepsy Behav; 2017 Mar; 68():95-102. PubMed ID: 28135595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfaction as a marker for depression.
    Croy I; Hummel T
    J Neurol; 2017 Apr; 264(4):631-638. PubMed ID: 27393116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizure treatment with olfactory training: a preliminary trial.
    Yilmaz Y; Turk BG; Ser MH; Sut NY; Sahin S; Yildiz EP; Bektas G; Teber ST; Tekeli H; Ozkara C
    Neurol Sci; 2022 Dec; 43(12):6901-6907. PubMed ID: 36066675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery.
    Shringarpure M; Gharat S; Momin M; Omri A
    Expert Opin Drug Deliv; 2021 Feb; 18(2):169-185. PubMed ID: 32921169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of a depression self-management intervention on seizure activity.
    Thompson NJ; McGee RE; Garcia-Williams A; Selwa LM; Stoll SC; Johnson EK; Fraser RT
    Epilepsy Behav; 2020 Feb; 103(Pt A):106504. PubMed ID: 31648928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of SARS-CoV-2 infection on seizure, anxiety, and depression in 107 patients with epilepsy.
    Zhou S; Zhang D; Chang J; Xia Z; Li J; Ni M; Li H
    Epilepsy Behav; 2023 Aug; 145():109290. PubMed ID: 37406559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying the burden of generalized tonic-clonic seizures in patients with drug-resistant epilepsy.
    Sheikh SR; Thompson N; Frech F; Malhotra M; Jehi L
    Epilepsia; 2020 Aug; 61(8):1627-1637. PubMed ID: 32658343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychogenic non-epileptic seizures with and without epilepsy: Exploring the influence of co-existing psychiatric disorders on clinical characteristics and outcomes.
    ALKhaldi NA; Paredes-Aragón E; Kim DD; Yu YJ; ALKhateeb M; Mirsattari SM
    Epilepsy Res; 2024 Jan; 199():107279. PubMed ID: 38101178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-morbidity of epilepsy in Tanzanian children: a community-based case-control study.
    Burton K; Rogathe J; Whittaker RG; Mankad K; Hunter E; Burton MJ; Todd J; Neville BG; Walker R; Newton CR
    Seizure; 2012 Apr; 21(3):169-74. PubMed ID: 22130004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.